1 Lee, CK, Park, KK, Lim, SS, et al. (2007) Effects of the licorice extract against tumor growth and cisplatin-induced toxicity in a mouse xenograft model of colon cancer. Biol Pharm Bull 30, 2191–2195.
2 Adams, LS, Seeram, NP, Hardy, ML, et al. (2006) Analysis of the interactions of botanical extract combinations against the viability of prostate cancer cell lines. Evid Based Complement Alternat Med 3, 117–124.
3 Jo, EH, Kim, SH, Ra, JC, et al. (2005) Chemopreventive properties of the ethanol extract of chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett 230, 239–247.
4 Ma, J, Peng, W & Liang, D (2000) Apoptosis of human gastric cancer cell line MGC-803 induced by Glycyrrhiza uralensis extract. Zhongguo Zhong Xi Yi Jie He Za Zhi 20, 928–930.
5 Wang, ZY & Nixon, DW (2001) Licorice and cancer. Nutr Cancer 39, 1–11.
6 Asl, MN & Hosseinzadeh, H (2008) Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22, 709–724.
7 Kobayashi, M, Fujita, K, Katakura, T, et al. (2002) Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma. Anticancer Res 22, 4053–4058.
8 Hibasami, H, Iwase, H, Yoshioka, K, et al. (2005) Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int J Mol Med 16, 233–236.
9 Hibasami, H, Iwase, H, Yoshioka, K, et al. (2006) Glycyrrhetic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int J Mol Med 17, 215–219.
10 Thirugnanam, S, Xu, L, Ramaswamy, K, et al. (2008) Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP. Oncol Rep 20, 1387–1392.
11 Hattori, M, Sakamoto, T, Kobashi, K, et al. (1983) Metabolism of glycyrrhizin by human intestinal flora. Planta Med 48, 38–42.
12 Stormer, FC, Reistad, R & Alexander, J (1993) Glycyrrhizic acid in liquorice – evaluation of health hazard. Food Chem Toxicol 31, 303–312.
13 van Uum, SH (2005) Liquorice and hypertension. Neth J Med 63, 119–120.
14 Choi, HJ, Seon, MR, Lim, SS, et al. (2008) Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts. Exp Biol Med 233, 1554–1560.
15 Jemal, A, Siegel, R, Ward, E, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58, 71–96.
16 Steeg, PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12, 895–904.
17 Bogenrieder, T & Herlyn, M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22, 6524–6536.
18 Yoon, SO, Park, SJ, Yun, CH, et al. (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 36, 128–137.
19 Zhang, L, Shi, J, Feng, J, et al. (2004) Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer. Prostate Cancer Prostatic Dis 7, 327–332.
20 Crippa, MP (2007) Urokinase-type plasminogen activator. Int J Biochem Cell Biol 39, 690–694.
21 Orian-Rousseau, V & Ponta, H (2008) Adhesion proteins meet receptors: a common theme? Adv Cancer Res 101, 63–92.
22 Okegawa, T, Pong, RC, Li, Y, et al. (2004) The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 51, 445–457.
23 Moll, UM, Youngleib, GL, Rosinski, KB, et al. (1990) Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res 50, 6162–6170.
24 Azzam, HS & Thompson, EW (1992) Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res 52, 4540–4544.
25 Cho, HJ, Kim, WK, Kim, EJ, et al. (2003) Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am J Physiol Gastrointest Liver Physiol 284, G996–1005.
26 Kwon, GT, Cho, HJ, Chung, WY, et al. (2009) Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 20, 663–676.
27 Howard, EW, Bullen, EC & Banda, MJ (1991) Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266, 13064–13069.
28 Li, Y & Cozzi, PJ (2007) Targeting uPA/uPAR in prostate cancer. Cancer Treat Rev 33, 521–527.
29 Fukai, T, Toyono, M & Nomura, T (1988) On the structure of licoricidin. Heterocycles 27, 2309–2313.
30 Cho, HJ, Lim, SS, Lee, YS, et al. (2010) Hexane/ethanol extract of Glycyrrhiza uralensis licorice exerts potent anti-inflammatory effects in murine macrophages and in mouse skin. Food Chem 121, 959–966.
31 Hawthorne, S & Gallagher, S (2008) Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells. J Pharm Pharmacol 60, 661–666.
32 Shibata, S, Inoue, H, Iwata, S, et al. (1991) Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice. Planta Med 57, 221–224.
33 Yamazaki, S, Morita, T, Endo, H, et al. (2002) Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Lett 183, 23–30.
34 Agarwal, MK, Iqbal, M & Athar, M (2005) Inhibitory effect of 18beta-glycyrrhetinic acid on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in mice. Redox Rep 10, 151–157.
35 Fukai, T, Marumo, A, Kaitou, K, et al. (2002) Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci 71, 1449–1463.
36 Hatano, T, Kusuda, M, Inada, K, et al. (2005) Effects of tannins and related polyphenols on methicillin-resistant Staphylococcus aureus. Phytochemistry 66, 2047–2055.
37 Lambert, E, Dasse, E, Haye, B, et al. (2004) TIMPs as multifacial proteins. Crit Rev Oncol Hematol 49, 187–198.
38 Jiang, Y, Goldberg, ID & Shi, YE (2002) Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21, 2245–2252.
39 Soula-Rothhut, M, Coissard, C, Sartelet, H, et al. (2005) The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. Exp Cell Res 304, 187–201.
40 Honkavuori, M, Talvensaari-Mattila, A, Puistola, U, et al. (2008) High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma. Anticancer Res 28, 2715–2719.
41 Blasi, F & Verde, P (1990) Urokinase-dependent cell surface proteolysis and cancer. Semin Cancer Biol 1, 117–126.
42 Folkman, J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29, 15–18.
43 Hicklin, DJ & Ellis, LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23, 1011–1027.
44 Goh, PP, Sze, DM & Roufogalis, BD (2007) Molecular and cellular regulators of cancer angiogenesis. Curr Cancer Drug Targets 7, 743–758.
45 Christofori, G (2006) New signals from the invasive front. Nature 441, 444–450.